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ABSTRACT
Objectives To estimate the population prevalence of
symptomatic radiographic osteoarthritis (OA) affecting
the 1st metatarsophalangeal joint (MTPJ), 1st and 2nd
cuneometatarsal joints (CMJs), navicular first cuneiform
joint (NCJ) and talonavicular joint (TNJ) in community-
dwelling older adults.
Methods 9334 adults aged ≥50 years registered with
four general practices were mailed a health survey.
Responders reporting foot pain within the last
12 months were invited to undergo weight-bearing
dorso-plantar and lateral radiographs of both feet. OA at
the 1st MTPJ, 1st and 2nd CMJs, NCJ and TNJ was
graded using a validated atlas. Population prevalence
estimates for symptomatic radiographic foot OA overall
and for each joint were calculated using multiple
imputation and weighted logistic regression modelling to
account for missing data and non-response.
Results 5109 health surveys were received (adjusted
response 56%). Radiographs were obtained on 557
participants. Overall population prevalence of
symptomatic radiographic OA was 16.7% (95% CI
15.3% to 18.0%), 1st MTPJ 7.8% (6.7% to 8.9%), 1st
CMJ 3.9% (2.9% to 4.9%), 2nd CMJ 6.8% (5.7% to
7.8%), NCJ 5.2% (4.0% to 6.4%) and TNJ 5.8% (4.8%
to 6.9%). With the exception of the 1st CMJ, prevalence
was greater in females than males, increased with age
and was higher in lower socioeconomic classes. Three-
quarters of those with symptomatic radiographic OA
reported disabling foot symptoms.
Conclusions While cautious interpretation due to non-
response is warranted, our study suggests that
symptomatic radiographic foot OA affects one in six
older adults and the majority report associated disability.
Clinicians should consider OA as a possible cause of
chronic foot pain in older people.
INTRODUCTION
Symptomatic osteoarthritis (OA) is common in the
general population and affects the lives of 10% of
people aged over 60 years.1 OA accounts for 15%
of all musculoskeletal consultations in those aged
45 years and over in primary care.2 It has a major
impact on quality of life,3 locomotor function,4
social participation5 and economic productivity.6
The foot is recognised as a target region for OA
and was included in early descriptions of general-
ised OA,7 yet it is the least-studied joint complex
commonly affected by OA.8 Although foot pain is
prevalent among community-dwelling older
adults9–13 and frequently leads to consultation in
primary care,14 how OA contributes to this is
unclear. Previous studies focused mainly on the 1st
metatarsophalangeal joint (MTPJ), examined radio-
graphic OA irrespective of pain or were undertaken
in highly selected populations.8 15 16 The few
studies that have compared the prevalence of radio-
graphic OA at multiple sites within the foot suggest
that the 1st MTPJ is more frequently affected than
the midfoot joints and lesser MTPJs.8 Following
the recent development of a radiographic atlas for
foot OA,17 two studies undertaken in populations
of retirement village residents found that the preva-
lence of radiographic OA was highest at the 2nd
cuneometatarsal joint (CMJ).15 16 However, these
studies do not relate the presence of radiographic
OA to foot pain. Furthermore, the relative preva-
lence of symptomatic radiographic OA at different
joints within the foot in the general population is
not known. Such information is needed to provide
a basis for understanding the aetiology of foot OA,
to understand the community burden of symptom-
atic foot OA and inform healthcare provision and
clinical need.
The objective of this study was to estimate the
population prevalence of (1) symptomatic radio-
graphic OA and (2) disabling symptomatic radio-
graphic OA affecting the 1st MTPJ, 1st and 2nd
CMJs, navicular first cuneiform joint (NCJ) and
talonavicular joint (TNJ) in community-dwelling
adults aged 50 years and over.
METHODS
Study design
This paper uses baseline data from a 3-year
population-based prospective observational cohort,
the Clinical Assessment Study of the Foot
(CASF).18 Adults aged 50 years and over registered
with four general practices were invited to take
part in the study, irrespective of consultation for
foot pain or problems.
Data collection
All eligible participants were mailed a health survey
questionnaire that gathered information on aspects
of general health, including Short Form-12
(SF-12),19 Hospital Anxiety and Depression Scale
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(HADS),20 anthropometric characteristics (self-reported height
and weight), foot pain and demographic and socioeconomic
characteristics (age, gender, marital status, higher education,
current employment status and occupation). Specific questions
asked about foot pain included pain in and around the foot in
the past 12 months; pain, aching or stiffness in the foot in the
past month21; number of days with foot pain in the past
12 months; and the Manchester Foot Pain and Disability Index
(MFPDI).22 Participants were asked to indicate the location of
foot pain experienced in the right and left feet in the past
month by shading on a foot manikin (© The University of
Manchester 2000. All rights reserved).23 Non-responders to the
health survey questionnaire were sent a reminder postcard after
2 weeks. Those who did not respond to the reminder postcard
were sent a repeat health survey questionnaire 4 weeks after the
initial mailing. Participants who reported pain in and around
the foot in the past 12 months and provided written consent to
further contact were invited to attend a research assessment
clinic where weight-bearing dorso-plantar and lateral radio-
graphs of each foot were obtained according to a defined stan-
dardised protocol.17 Participants were asked to consent to
review of their medical records by the research team.
Scoring of radiographs
Plain radiographs were scored by a single reader (MM) blind to
all other participant information. Osteophytes and joint space
narrowing at the 1st MTPJ, 1st and 2nd CMJs, NCJ and TNJ
were scored (0–3) according to a validated atlas.17 Radiographic
OA at each individual joint was defined as a score of 2 or more
for osteophytes or joint space narrowing on either dorso-plantar
or lateral views.
To establish intra-rater and inter-rater reliability for the pres-
ence of OA in each joint, radiographs from 60 randomly
selected participants were rescored 8 weeks later by MM and
scored by a second blind assessor (HBM). Intra-rater reliability
was excellent (mean unweighted k=0.94, mean % agree-
ment=99%), whereas inter-rater reliability was moderate (mean
unweighted k=0.46, mean % agreement=79%).24
Inflammatory arthritis exclusions
Participants were excluded from the current analyses if medical
records (primary care and local hospital) or a clinical X-ray
report by a consultant musculoskeletal radiologist identified
them as having inflammatory arthritis (non-specific inflamma-
tory arthritis, rheumatoid arthritis or psoriatic arthritis).
Case definitions
Symptomatic radiographic OA at each individual joint was
defined as radiographic OA (as defined above) together with
pain in the past 4 weeks occurring in the corresponding region
of the same foot on the foot manikin, as described by Garrow
et al.23 Individuals were defined as having symptomatic radio-
graphic OA at each joint if either or both feet were affected.
Overall symptomatic radiographic OA was defined as symptom-
atic radiographic OA in at least one of the five joints assessed.
Disabling symptomatic radiographic OA at each individual
joint was defined as symptomatic radiographic OA at that joint
(as defined above) together with at least 1 of the 10 items
within the MFPDI function construct scored at the level of ‘on
most/every day(s)’.25 Where all 10 items were scored as occur-
ring ‘none of the time’ or ‘on some days’, foot pain was consid-
ered non-disabling. Individuals were defined as having disabling
symptomatic radiographic OA at each joint if either or both feet
were affected. Overall disabling symptomatic radiographic OA
was defined as disabling symptomatic radiographic OA in at
least one of the five joints assessed.
Statistical analysis
Describing the sample
The sample size calculation for CASF was undertaken to ensure
that sufficient numbers of participants were recruited to the
research clinic to sufficiently power longitudinal analyses.18 As
such, a specific sample size calculation for this cross-sectional
analysis was not performed. To determine the extent of selective
non-participation, we compared the characteristics (age, gender
and practice distribution) of health survey questionnaire respon-
ders with the mailed population. Selective non-response and
non-consent were evaluated at each subsequent selection point
(health survey questionnaire response, reported pain in and
around the foot in the past 12 months, reported pain in and
around the foot in the past 12 months and provided consent to
further contact, attended research assessment clinic) by compar-
ing marital status, higher education, employment status, occupa-
tional class, SF-12, HADS anxiety and depression subscales,
body mass index, disabling foot pain,25 number of days in the
past 12 months with foot pain and Rasch MFPDI scores
between participants at each point.
Estimating population prevalence
Using baseline health survey questionnaire and radiographic data,
the population prevalence of (1) symptomatic radiographic foot
OA and (2) disabling symptomatic radiographic foot OA, in the
individual overall and at each joint, were estimated using multiple
imputation and weighted logistic regression modelling. Missing
data arose from non-completion of individual items within the
health survey questionnaire or questionnaire non-response.
Missing item-level data were imputed using multiple imputation.
Estimates were then weighted to take into account non-response.
The assumption that data were missing at random was verified.
The imputation process was applied to all baseline responders
to impute baseline variables using appropriate distributions. We
have previously shown that the MFPDI fits the Rasch model.26
Prior to inclusion in the imputation model, the MFPDI variable
was Rasch-modelled to generate interval-level scores for both its
pain and function constructs. The imputation model included
age, gender, general practice, social class, marital status, number
of days in the past 12 months with foot pain, Rasch MFPDI
pain and function scores, individual MFPDI function items (to
determine disabling foot pain25), report of pain, aching or stiff-
ness in the foot in the last month, SF-12 score, HADS score and
foot OA and pain regions. The number of imputations was set
at 15, and imputed data sets were combined using Rubin’s com-
bination rules.27 The mim: proportion command was used to
determine the prevalence estimates (and 95% CIs ) for the total
baseline responder population. The estimates were weighted to
account for any initial selective non-response from the eligible
baseline population to the health survey. Information on age,
gender and general practice location was available for all indivi-
duals and was used to determine a weight to reflect the likeli-
hood that a person, with a particular combination of age,
gender and practice location, would return the health survey
questionnaire. Weighted logistic regression, within the imputed
data sets, was performed to determine prevalence estimates (and
95% CI) in the total baseline eligible mailed population.
Population prevalence estimates for symptomatic radiographic
foot OA were then stratified by gender, age group and socio-
economic class. All analyses were conducted using STATAV.12.0
(Stata Corporation, Texas, USA).
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RESULTS
Study population
In 2010/2011, the baseline health survey questionnaire was
mailed to 9334 adults aged 50 years and over (figure 1). During
the mailing process, 140 exclusions due to deaths, departures
from the general practitioner practices, incorrect addresses and
ill-health (dementia, severe or terminal illness) were identified,
leaving an eligible baseline population of 9194. In total, 5109
completed health survey questionnaires were received (adjusted
response 56%). Of these, 1635 individuals who reported pain
in and around the foot in the past 12 months and provided
consent to further contact were invited to the research assess-
ment clinic and 560 attended. The median time between receiv-
ing the completed health survey questionnaire and clinic
attendance was 37 days (IQR 27–47). Participants with incom-
plete radiographs (n=3), incomplete foot pain data (n=8) and
inflammatory arthritis (n=24) were excluded, leaving a total of
525 eligible clinic attenders with complete data.
Figure 1 Flowchart showing recruitment of participants into study.
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Selective non-participation
The age, gender and practice distribution of the samples at the
various selection points were broadly representative of the base-
line eligible population, although women aged 75 years and
over were under-represented among clinic attenders (table 1).
Demographic, general health, psychological and lifestyle char-
acteristics were available on the 5109 respondents to the health
survey (table 2). Clinic attenders were more likely to have
attended higher education and have managerial, administrative
or professional occupations, had a higher number of days of
foot pain and greater impairment in function on the MFPDI.
Frequency of symptomatic radiographic foot OA in clinic
attenders
Of 525 eligible clinic attenders, 188 (35.8%) had symptomatic
radiographic foot OA affecting at least one of the five joints.
The 1st MTPJ was most commonly affected (n=93), followed
by the 2nd CMJ (n=67), TNJ (n=53), NCJ (n=36) and 1st
CMJ (n=22).
Population prevalence of symptomatic radiographic foot OA
Population prevalence estimates were almost identical in the
baseline responder population and the total baseline eligible
mailed population, hence the latter data are presented. The
population prevalence of symptomatic radiographic foot OA in
adults aged 50 years and over was 16.7% (95% CI 15.3% to
18.0%). The most commonly affected joint was the 1st MTPJ
(7.8%; 95% CI 6.7% to 8.9%), followed by the 2nd CMJ
(6.8%; 95% CI 5.7% to 7.8%), TNJ (5.8%; 95% CI 4.8% to
6.9%), NCJ (5.2%; 95% CI 4.0% to 6.4%) and 1st CMJ
(3.9%; 95% CI 2.9% to 4.9%) (table 3).
Symptomatic radiographic foot OA overall was more preva-
lent in females than males, at older ages and in lower
socioeconomic classes. The prevalence remained lower in the
managerial/professional class after stratification by age and
gender. Similar patterns were seen at the 1st MTPJ, 2nd CMJ,
NCJ and TNJ. However, the population prevalence of symp-
tomatic radiographic OA at the 1st CMJ did not differ by age
and gender.
Frequency of disabling symptomatic radiographic foot OA
in clinic attenders
Of the 188 participants with symptomatic radiographic foot
OA, 130 (69%) reported disabling foot symptoms. Again, the
1st MTPJ was most commonly affected (n=58), followed by the
2nd CMJ (n=52), TNJ (n=41), NCJ (n=24) and 1st CMJ
(n=15). In addition, after excluding inflammatory arthritis, 129
clinic attenders had disabling foot pain but did not meet criteria
for radiographic foot OA. Seventy-eight (60%) of these had
grade 1 osteophyte or joint space narrowing in one or more
joints in either foot.
Population prevalence of disabling symptomatic
radiographic foot OA
The population prevalence of disabling symptomatic radio-
graphic foot OA in adults aged 50 years and over was 12.6%
(95% CI 11.5% to 13.7%). Pain was most commonly disabling
at the 1st MTPJ (5.6%; 95% CI 4.7% to 6.6%) and the 2nd
CMJ (5.6%; 95% CI 4.7% to 6.6%), followed by the TNJ (4.7%;
95% CI 3.9% to 5.6%), the NCJ (4.1%; 95% CI 3.1% to 5.0%)
and the 1st CMJ (3.1%; 95% CI 2.2% to 3.9%) (table 4).
The proportion of individuals with symptomatic radiographic
foot OA who reported disabling symptoms was as follows:
overall 75.4%, 1st MTPJ 71.7%, 2nd CMJ 82.4%, TNJ 81.0%,
NCJ 78.8% and 1st CMJ 79.5%.
Table 1 Age, gender and practice differences between exclusions, non-responders and responders at each baseline selection point
All mailed
participants Exclusions
Non-responders
and refusals Responders
Reported foot
pain in the last
12 months
Eligible for
invite to
clinic
Attended
research
clinic
N 9334 140 4085 5109 2086 1635 560
Practice
A 2515 (27) 38 (27) 906 (22) 1571 (31) 592 (28) 488 (30) 191 (34)
B 3218 (34) 52 (37) 1585 (39) 1581 (31) 666 (32) 526 (32) 176 (31)
C 1785 (19) 27 (19) 857 (21) 901 (18) 361 (17) 269 (16) 86 (15)
D 1816 (19) 23 (16) 737 (18) 1056 (21) 467 (22) 352 (22) 107 (19)
Gender
Males 4611 (49) 90 (64) 2082 (51) 2439 (48) 887 (43) 710 (43) 247 (44)
Females 4723 (51) 50 (36) 2003 (49) 2670 (52) 1199 (57) 925 (57) 313 (56)
Age
50–64 5126 (55) 60 (43) 2503 (61) 2563 (50) 1073 (51) 896 (55) 300 (54)
65–74 2443 (26) 28 (20) 885 (22) 1530 (30) 608 (29) 471 (29) 179 (32)
75+ 1765 (19) 52 (37) 697 (17) 1016 (20) 405 (19) 268 (16) 81 (14)
Age, males
50–64 2687 (58) 41 (46) 1383 (66) 1263 (52) 499 (56) 418 (59) 139 (56)
65–74 1212 (26) 15 (17) 441 (21) 756 (31) 250 (28) 195 (27) 74 (30)
75+ 712 (15) 34 (38) 258 (12) 420 (17) 138 (16) 97 (14) 34 (14)
Age, females
50–64 2439 (52) 19 (38) 1120 (56) 1300 (49) 574 (48) 478 (52) 161 (51)
65–74 1231 (26) 13 (26) 444 (22) 774 (29) 358 (30) 276 (30) 105 (34)
75+ 1053 (22) 18 (36) 439 (22) 596 (22) 267 (22) 171 (18) 47 (15)
Figures represent numbers and percentages.
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DISCUSSION
While cautious interpretation is warranted due to non-response,
our study suggests that one in six adults aged 50 years and over
have symptomatic radiographic OA affecting at least one of the
five foot joints studied in either or both feet. The most com-
monly affected joint was the 1st MTPJ, followed by the 2nd
CMJ, TNJ, NCJ and 1st CMJ. The prevalence of symptomatic
radiographic foot OA generally increased with age, particularly
Table 2 Demographics, general health, psychological and lifestyle characteristics at each baseline selection point
Responded to health
survey
Reported foot pain in
the last 12 months
Eligible for
invite to clinic
Attended
research clinic
N 5109 2086 1635 560
Marital status
Married/co-habiting 3466 (68) 1368 (66) 1096 (67) 388 (69)
Divorced/separated 473 (9) 207 (10) 173 (11) 57 (10)
Widowed 806 (16) 367 (18) 264 (16) 85 (15)
Single 296 (6) 110 (5) 79 (5) 28 (5)
Missing 68 (1) 34 (2) 23 (1) 2 (1)
Higher education
Yes 843 (17) 368 (18) 323 (20) 145 (26)
No 3996 (78) 1615 (77) 1253 (77) 398 (71)
Missing 270 (5) 103 (5) 59 (4) 17 (3)
Employment status
Employed 1442 (28) 510 (24) 432 (26) 121 (22)
Retired 2831 (55) 1140 (55) 859 (53) 338 (60)
Unable due to illness 305 (6) 187 (9) 150 (9) 44 (8)
Unemployed 71 (1) 31 (1) 25 (2) 8 (1)
Housewife 179 (4) 94 (5) 76 (5) 27 (5)
Other 143 (3) 59 (3) 51 (3) 17 (3)
Missing 138 (3) 65 (3) 42 (3) 5 (1)
Occupational class
Managerial/administrative/professional 1011 (20) 352 (17) 307 (19) 145 (26)
Intermediate 887 (17) 356 (17) 293 (18) 98 (18)
Routine/manual 2668 (52) 1149 (55) 891 (55) 282 (50)
Other* 543 (11) 229 (11) 144 (9) 35 (6)
Baseline SF-12: mean (SD)
Physical (0–100) 41.54 (12.43) 37.07 (12.15) 37.50 (12.24) 38.00 (12.28)
Missing 628 (12) 280 (13) 179 (11) 41 (7)
Mental (0–100) 49.24 (11.37) 46.68 (12.02) 47.18 (11.88) 48.88 (11.11)
Missing 628 (12) 280 (13) 179 (11) 41 (7)
Baseline HADS anxiety
None (0–7) 3037 (59) 984 (47) 809 (49) 307 (55)
Possible (8–11) 1194 (23) 608 (29) 465 (28) 154 (28)
Probable (12–21) 776 (15) 461 (22) 336 (21) 91 (16)
Missing 102 (2) 33 (2) 25 (2) 8 (1)
Baseline HADS depression
None (0–7) 3637 (71) 1277 (61) 1049 (64) 389 (69)
Possible (8–11) 922 (18) 501 (24) 368 (23) 119 (21)
Probable (12–21) 451 (9) 275 (13) 193 (12) 44 (8)
Missing 99 (2) 33 (2) 25 (2) 8 (1)
BMI (kg/m2)
<20 174 (3) 58 (3) 37 (2) 11 (2)
20.0–24.9 1510 (3) 522 (25) 396 (24) 132 (24)
25.0–29.9 1948 (38) 768 (37) 605 (37) 221 (39)
≥30 1229 (24) 651 (31) 538 (33) 191 (34)
Missing 248 (5) 87 (4) 59 (4) 5 (1)
Disabling foot pain†
Yes – 862 (63) 683 (62) 283 (63)
No – 404 (30) 354 (32) 68 (34)
Missing – 100 (7) 68 (6) 16 (4)
Number of days with foot pain‡
Less than 7 days – 343 (16) 276 (17) 74 (13)
1–4 weeks – 291 (14) 226 (14) 68 (12)
1–3 months – 256 (12) 196 (12) 66 (12)
Continued
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among women, and was higher in lower socioeconomic classes.
The exception to this observation was the 1st CMJ, where age
and gender patterns were not evident, although this joint had
the lowest prevalence of OA (3.9%). Levels of disability were
high at all sites, with three-quarters of those with symptomatic
radiographic foot OA reporting disabling foot symptoms. The
proportion of those with symptomatic radiographic OA who
reported disabling symptoms was lower at the 1st MTPJ com-
pared with the midfoot joints.
To our knowledge, this is the first study to report the popula-
tion prevalence of symptomatic radiographic foot OA.
Numerous previous studies have reported the prevalence of
radiographic foot OA 8 or the association between radiographic
foot OA and foot pain,15 16 but none report the proportion
with painful radiographic foot OA. Not surprisingly, the preva-
lence estimates for symptomatic radiographic foot OA obtained
in our study are lower than those in the published literature for
radiographic foot OA irrespective of symptoms. Surveys
undertaken in populations comparable to ours estimate the
prevalence of radiographic OA at the 1st MTPJ (Kellgren and
Lawrence grade ≥2 28) to range from 20% to 35% in
middle-aged and older adults.8 29–33 Using the same validated
atlas in an older population, Menz et al15 also found that the
2nd CMJ is the most commonly affected of the four midfoot
joints studied. The base of the second metatarsal, forming the
2nd CMJ, is the keystone of the transverse arch and occupies a
recessed position relative to the first and third metatarsals,
potentially making the 2nd CMJ more susceptible to excess
loading and development of OA.34 When compared with esti-
mates of symptomatic OA at the knee, hip and hand from
similar populations of older adults,35 the overall prevalence of
symptomatic radiographic foot OA in our study is higher than
the hip (5.0–7.4%), similar to the knee (7.6–16.4%) and lower
than the hand (21.6%).
Strengths of our study include the population size, the
primary care setting and the combination of multiple imputation
Table 2 Continued
Responded to health
survey
Reported foot pain in
the last 12 months
Eligible for
invite to clinic
Attended
research clinic
N 5109 2086 1635 560
3+ months – 1158 (56) 918 (56) 348 (62)
Missing – 38 (2) 19 (1) 4 (1)
Rasch MFPDI: mean (SD)‡
Function – −0.36 (2.16) −0.49 (2.17) −0.58 (2.14)
Missing – 28 (1) 18 (1) 3 (1)
Pain – −0.31 (1.57) −0.35 (1.57) −0.20 (1.55)
Missing – 51 (2) 31 (2) 3 (1)
Figures represent numbers and percentages unless otherwise stated.
*Includes housewives, non-workers, retired people and those inadequately described.
†For those who reported foot pain in the last month.
‡For those who reported foot pain in the last year.
BMI, body mass index; HADS, Hospital Anxiety and Depression Scale; MFPDI, Manchester Foot Pain and Disability Index; SF12, Short-Form 12.
Table 3 Population prevalence of symptomatic foot OA by anatomical location and age, gender and socioeconomic classification
1st MTPJ 1st CMJ 2nd CMJ NCJ TNJ Overall
Symptomatic radiographic OA 7.8 (6.7 to 8.9) 3.9 (2.9 to 4.9) 6.8 (5.7 to 7.8) 5.2 (4.0 to 6.4) 5.8 (4.8 to 6.9) 16.7 (15.3 to 18.0)
Males 6.7 (5.3 to 8.0) 3.6 (2.4 to 4.9) 5.0 (3.8 to 6.2) 3.8 (2.4 to 5.2) 5.0 (3.4 to 6.7) 14.3 (12.6 to 16.0)
Females 8.8 (7.4 to 10.3) 4.2 (2.9 to 5.4) 8.5 (6.9 to 10.2) 6.7 (5.0 to 8.3) 6.6 (5.3 to 8.0) 18.9 (16.9 to 20.9)
Age
50–64 6.9 (5.5 to 8.2) 4.1 (2.8 to 5.4) 6.0 (4.6 to 7.4) 4.8 (3.4 to 6.2) 5.6 (4.1 to 7.1) 15.9 (13.9 to 17.9)
65–74 8.7 (6.6 to 10.8) 3.5 (2.2 to 4.7) 6.4 (4.8 to 7.9) 4.9 (3.1 to 6.8) 5.7 (4.1 to 7.2) 17.0 (14.8 to 19.2)
75+ 9.0 (6.7 to 11.2) 3.9 (1.6 to 6.2) 9.8 (7.2 to 12.5) 7.0 (4.7 to 9.3) 7.0 (4.8 to 9.1) 18.5 (15.8 to 21.1)
Age, males
50–64 5.8 (4.1 to 7.5) 4.0 (2.3 to 5.7) 4.6 (3.1 to 6.0) 3.5 (1.9 to 5.2) 5.0 (2.8 to 7.2) 13.9 (11.5 to 16.3)
65–74 8.0 (5.5 to 10.6) 3.2 (1.3 to 5.2) 4.6 (2.6 to 6.7) 3.6 (1.7 to 5.6) 4.6 (2.5 to 6.8) 15.0 (12.0 to 18.0)
75+ 7.1 (4.3 to 9.9) 2.9 (0.3 to 5.4) 7.2 (4.3 to 10.2) 4.9 (2.1 to 7.6) 5.9 (3.0 to 8.8) 14.4 (10.8 to 18.1)
Age, females
50–64 7.9 (6.1 to 9.8) 4.3 (2.4 to 6.2) 7.5 (5.0 to 10.0) 6.1 (4.1 to 8.1) 6.1 (4.3 to 7.9) 17.9 (15.1 to 20.6)
65–74 9.4 (6.5 to 12.3) 3.7 (1.7 to 5.6) 8.2 (6.0 to 10.4) 6.3 (3.6 to 8.9) 6.7 (4.1 to 9.4) 19.0 (15.6 to 22.4)
75+ 10.3 (7.3 to 13.4) 4.7 (1.7 to 7.7) 11.7 (8.0 to 15.5) 8.6 (5.1 to 12.2) 7.7 (4.8 to 10.6) 21.4 (17.7 to 25.2)
Socioeconomic classification
Managerial and professional 4.8 (3.3 to 6.3) 2.5 (0.8 to 4.1) 3.7 (2.1 to 5.3) 2.5 (0.9 to 4.2) 3.8 (2.1 to 5.5) 10.2 (8.0 to 12.5)
Intermediate occupations 8.7 (5.9 to 11.5) 4.0 (1.0 to 7.0) 6.9 (4.6 to 9.2) 6.1 (3.7 to 8.6) 6.1 (3.0 to 9.3) 17.9 (14.7 to 21.1)
Routine and manual 8.3 (6.6 to 10.0) 4.1 (2.9 to 5.4) 7.3 (5.7 to 8.9) 6.1 (4.6 to 7.6) 6.4 (4.9 to 7.8) 18.2 (16.2 to 20.1)
CMJ, cuneometatarsal joint; OA, osteoarthritis; MTPJ, metatarsophalangeal joint; NCJ, navicular first cuneiform joint; TNJ, talonavicular joint.
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and weighted logistic regression modelling to account for
missing data and non-response. A further strength is the use of a
standardised protocol to obtain radiographs of both feet and a
validated atlas and scoring system to grade features of OA at
multiple foot joints.17 Previous studies of radiographic foot OA
are limited by focusing on the 1st MTPJ, using unspecified or
uniplanar radiographic views or taking non-weight-bearing
views.8 The limitations of our study are worthy of acknowledge-
ment. The overall response to the postal health survey question-
naire was lower than we had expected when compared with
response in our previous population surveys 36 37 despite the
use of several strategies to increase response to postal question-
naire surveys.18 38 39 Responders to the health survey question-
naire did not appear to differ greatly from the mailed
population by age, gender or practice distribution. Inverse prob-
ability weighting based on these variables still leaves potential
non-response bias related to other determinants of response
associated with foot pain and radiographic OA. Similarly, only
one-third of health survey questionnaire responders who were
eligible to attend the research assessment clinic did so. Those in
managerial, administrative or professional occupations and those
who received higher education were over-represented in clinic
attenders. In terms of the external validity of our findings, the UK
population census 2011 suggests that the source population has a
low representation of ethnic minority groups but does not differ
from the national picture in terms of age and gender.40 Intra-rater
reliability for the presence of OA in a joint was excellent, whereas
inter-rater reliability was only moderate, concurring with the ori-
ginal validation of the atlas.17 However, it became apparent that
the main assessor systematically took a more conservative
approach to scoring radiographic features than the second asses-
sor. Therefore, the population prevalence of symptomatic radio-
graphic foot OA is possibly underestimated. This is particularly
true of our overall prevalence estimate, which is based only on
the five joints assessed in the atlas and does not include other
joints within the foot. Observations regarding inter-rater reliability
provide further support for the previous recommendation that
single examiners or consensus approaches should be employed
when scoring radiographs for research purposes.16 41
The main clinical implication of our findings arises from the
prevalence of symptomatic radiographic foot OA and associated
disability suggesting that this poses a significant public health
problem that increases with age. Approximately 20% of people
with musculoskeletal foot problems consult their general practi-
tioner over a 3-year period14; therefore, our findings suggest
that clinicians should be aware of OA as a possible cause of
chronic foot pain in older people. In addition, a significant
number had disabling foot pain and milder radiographic features
and may be at risk of future progression and are therefore of
potential importance for early recognition and intervention.
Recognition of foot OA in primary care would be enhanced by
a better understanding of which clinical foot OA phenotypes
present to primary care and how they are diagnosed in this
setting. It would be worthwhile exploring the contribution of
radiographic foot OA to clinical phenotypes and how these
present to and are diagnosed in primary care.
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Table 4 Population prevalence of disabling symptomatic foot OA by anatomical location, age and gender
1st MTPJ 1st CMJ 2nd CMJ NCJ TNJ Overall
Disabling symptomatic
radiographic OA
5.6 (4.7 to 6.6) 3.1 (2.2 to 3.9) 5.6 (4.7 to 6.6) 4.1 (3.1 to 5.0) 4.7 (3.9 to 5.6) 12.6 (11.5 to 13.7)
Males 4.9 (3.7 to 6.0) 2.7 (1.7 to 3.8) 4.0 (2.9 to 5.1) 2.8 (1.7 to 3.8) 3.9 (2.6 to 5.3) 10.6 (9.2 to 12.0)
Females 6.4 (5.1 to 7.6) 3.4 (2.3 to 4.5) 7.2 (5.7 to 8.7) 5.3 (3.9 to 6.7) 5.5 (4.3 to 6.7) 14.5 (12.8 to 16.2)
Age
50–64 4.6 (3.4 to 5.8) 3.1 (2.0 to 4.3) 4.8 (3.5 to 6.0) 3.5 (2.4 to 4.6) 4.4 (3.1 to 5.6) 11.5 (9.9 to 13.0)
65–74 5.9 (4.2 to 7.7) 2.7 (1.6 to 3.9) 5.2 (3.7 to 6.7) 3.8 (2.3 to 5.3) 4.5 (3.1 to 5.9) 12.4 (10.4 to 14.3)
75+ 8.3 (6.1 to 10.4) 3.5 (1.3 to 5.8) 9.0 (6.6 to 11.5) 6.2 (4.1 to 8.4) 6.2 (4.3 to 8.2) 16.6 (14.2 to 19.0)
Age, males
50–64 4.0 (2.5 to 5.4) 2.9 (1.5 to 4.2) 3.2 (2.0 to 4.3) 2.3 (1.1 to 3.5) 3.8 (2.0 to 5.5) 9.7 (7.8 to 11.5)
65–74 5.5 (3.4 to 7.6) 2.7 (1.0 to 4.4) 4.2 (2.2 to 6.2) 3.0 (1.4 to 4.7) 3.8 (1.8 to 5.8) 11.2 (8.6 to 13.7)
75+ 7.0 (4.2 to 9.8) 2.5 (0.1 to 5.0) 6.7 (3.9 to 9.5) 4.1 (1.6 to 6.5) 4.9 (2.1 to 7.6) 12.9 (9.4 to 16.4)
Age, females
50–64 5.3 (3.7 to 6.9) 3.4 (1.7 to 5.2) 6.4 (4.3 to 8.5) 4.8 (3.0 to 6.5) 5.0 (3.3 to 6.7) 13.3 (11.0 to 15.6)
65–74 6.4 (3.9 to 8.8) 2.8 (1.1 to 4.5) 6.2 (4.1 to 8.3) 4.5 (2.5 to 6.6) 5.3 (3.1 to 7.5) 13.6 (10.7 to 16.5)
75+ 9.2 (6.3 to 12.1) 4.3 (1.3 to 7.2) 10.8 (7.4 to 14.2) 7.9 (4.6 to 11.1) 7.3 (4.6 to 9.9) 19.3 (15.8 to 22.7)
CMJ, cuneometatarsal joint; OA, osteoarthritis; MTPJ, metatarsophalangeal joint; NCJ, navicular first cuneiform joint; TNJ, talonavicular joint.
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